Bone scintigraphy is frequently performed as part of the routine staging of patients with a wide variety of primary malignancies. Although it is a sensitive imaging modality, it is relatively nonspecific, and there are many potential causes of increased isotope uptake that can mimic metastatic disease. The procedure is performed with technetium 99m-labeled diphosphonates. The uptake of these radiopharmaceuticals depicts osteoblastic activity and regional blood flow to bone. By 2-6 hours after injection, about 50% of the injected dose is in the skeletal system and, therefore, delayed static imaging usually is performed at this time by using a gamma camera and a low-energy, high-resolution collimator [1, 2] . In this review, the following lesions and patterns of uptake will be discussed -benign bone lesions, degenerative disease, trauma, infection, superscans, softtissue uptake and artifacts.
Benign Bone Lesions
Many benign bone lesions demonstrate increased uptake of a radiopharmaceutical on bone scintigraphy; these are listed below.
Fibrous dysplasia. Fibrous dysplasia is a relatively common benign skeletal disorder in which the normal medullary space is replaced by fibro-osseous tissue. It can affect just a single bone (monostotic) or multiple bones (polyostotic). Typically, fibrous dysplasia lesions exhibit markedly increased uptake of a radiopharmaceutical, and typical locations would include the skull base or multiple unilateral limb lesions ( Figure 1, A and B ). Bone scintigraphy is particularly useful in demonstrating the extent of disease in patients with polyostotic fibrous dysplasia [3] . Paget disease. Paget disease of bone is a metabolic disorder in which there is excessive and abnormal remodelling of bone. Typically, there are 3 phases: the lytic phase, the mixed phase, and the blastic phase. Bone scintigraphy typically demonstrates marked increased uptake of a radiopharmaceutical in all phases of Paget disease ( Figure 2 , A and B) [4] . In vertebrae, there is involvement of the whole bone (body and posterior elements), and, in long bones, the increased uptake extends from one end of the bone for a variable length throughout the bone. Enchondroma. Enchondromas are common benign cartilaginous neoplasms that occur in the medullary cavity of bone. Mild-to-moderate uptake of a radiopharmaceutical is usually demonstrated on bone scintigraphy ( Figure 3 , A-C) [5] . Bone island. An enostosis or bone island represents a focus of mature compact (cortical) bone within the cancellous bone. A distinguishing feature of bone islands is that they usually are photopenic on skeletal scintigraphy. However, giant bone islands (>2 cm) can show increased uptake of a radiopharmaceutical ( Figure 4 , A and B) [6, 7] . Hemangioma. Vertebral hemangiomas, when smaller than 3 cm in size, generally show normal uptake of a radiopharmaceutical. However, larger lesions may demonstrate either increased or decreased uptake ( Figure 5 ) [8] . Osteitis condensans ilii. Osteitis condensans ilii is benign sclerosis of the iliac side of the sacroiliac (SI) Lateral radiograph of the left knee, demonstrating a giant bone island in the distal left femoral shaft (arrow), with the long axis of the sclerotic lesion along the long axis of the femur, as is usually the case with bone islands. The subtle increase in radiopharmaceutical uptake on scintigraphy is explained by the increased volume of dense bone, without any increase in osteoblastic activity. Figure 5 . A 71-year-old woman with a history of breast cancer. Anterior bone scintigram (left), demonstrating significant increased uptake in the left side of the body of L1 suspicious for a metastasis. Computed tomography (CT) was suggestive of a vertebral hemangioma, with vertical spicules of bone in the lesion. However, in view of the increased uptake on bone scintigraphy, CT-guided biopsy (right) was performed, which confirmed that the lesion was a hemangioma. joints, which usually is bilaterally symmetrical and rarely unilateral. It usually is found in young multiparous women. Increased uptake of a radiopharmaceutical on the iliac side of affected Si joints is demonstrated ( Figure  6 , A and B) [9] . Eosinophilic granuloma. Eosinophilic granuloma is a form of Langerhans cell histiocytosis and usually is seen in pediatric patients. It has many radiographic appearances and may be a well-defined lytic lesion without a rim of sclerosis, or it may be ill defined and permeative in appearance. The scintigraphic findings vary from either a photopenic area or a focal area of increased uptake [5] .
Melorheostosis. Melorheostosis is a rare, benign, sclerosing bone dysplasia that demonstrates dense bone formation, typically along the cortex of tubular bones. It has a ''dripping candle wax'' pattern on plain film. Bone scintigraphy typically shows moderately increased uptake of a radiopharmaceutical [10] . Osteoid osteoma. This is a benign tumour that consists of an osteoblastic mass or nidus surrounded by a zone of reactive sclerosis. Characteristically, there is increased uptake on bone scan, and the double-density sign, which consists of a small focus of increased activity (nidus) surrounded by a larger area of less-intense activity (reactive sclerosis), is helpful in diagnosis [11] . Exostosis. An exostosis, or osteochondroma, is a cartilage-covered bony projection on the external surface of bone. The scintigraphic appearances are variable and are directly correlated with the degree of enchondral bone formation. Generally, there is more prominent radiopharmaceutical uptake in osteochondromas in younger patients and osteochondromas without increased radiopharmaceutical uptake are more frequent in older patients [12] .
Degenerative Disease
Degenerative disease manifests as areas of increased uptake on radionuclide bone scans. It can be distinguished from metastatic disease by its characteristic locations (Figure 7 , A-C). The medial compartment of the knee, the hand (especially the base of the first metacarpal), the wrist, the shoulders, and the feet are classic locations for osteoarthritis [2] . Both sides of the joint can be involved in arthritis, but this is unusual in malignant disease. Degenerative changes in the spine can be more challenging because both metastasis and arthritic change can occur in the same location; single photon emission computed tomography can help to localize the uptake in the facet joints, which can avoid the need for further imaging in a patient with degenerative disease. However, lateral uptake of a radiopharmaceutical in the cervical spine is almost invariably benign (Figure 8 ) [13] .
Trauma
It is possible to distinguish metastatic disease from trauma by analysing the pattern of distribution of uptake. Multifocal rib fractures ( Figure 9A ) have a characteristic linear distribution. The characteristic appearance of sacral insufficiency fractures ( Figure 9B ) is fracture lines that run vertically through both sacral ala, medial to the SI joints, and a transverse fracture at the level of the SI joints. The fractures often have a characteristic ''butterfly'' or ''Honda sign'' appearance. Other typical sites for insufficiency fractures include the pubic bones, pubic rami, and supra-acetabular region of the iliac bone.
Infection
Three-phase bone scanning is the radionuclide procedure of choice for diagnosing osteomyelitis in bone, but it can be encountered on static images when staging malignant disease. On classic static delayed images, osteomyelitis appears as an area of focally increased radiopharmaceutical uptake. Multifocal osteomyelitis can simulate metastatic disease (Figure 10 , A-C) [14] .
Diffuse Symmetrical Increased Uptake in Bone (''Superscan'')
A superscan is defined as a bone scan that demonstrates markedly increased skeletal radiopharmaceutical uptake relative to the soft tissues [15] . Nonmalignant causes of a superscan include metabolic diseases, such as hyperparathyroidism ( Figure 11, A and B) , hyperthyroidism, renal osteodystrophy, and osteomalacia, or widespread bone lesions, such as widespread Paget disease. Nonmalignant superscans typically demonstrate a uniform pattern of increased uptake, whereas superscans in patients with widespread metastases demonstrate a nonuniform pattern of uptake ( Figure 11C ).
Soft-Tissue Uptake
Physiologic uptake can be demonstrated within the kidney, bowel, and breast. A congenital variant can be demonstrated incidentally, such as in the case of a horseshoe kidney ( Figure 12, A and B ). If the patient has had surgical diversion of the urinary tract ( Figure 12C) , then a radiopharmaceutical is excreted through the bowel conduit. Myocardial uptake can be seen in patients with previous myocardial infarction ( Figure 12D ), long-standing congestive heart failure, pericarditis, amyloidosis, and unstable angina, and after resuscitation or cardioversion. Inflammation within soft-tissue structures can cause increased uptake on bone scintigraphy, and soft-tissue uptake can be seen in patients with tendinopathy ( Figure 12 , E and F), bursitis, abscess, and crystalline arthropathy, and after radiation. Heterotopic ossification causes increased uptake due to the presence of extraskeletal osteoblasts. The orientation of the kidney on this whole-body scintigram is typical of that found in a horseshoe kidney, with the lower poles pointing medially (arrow). (B) A 50-year-old woman with a horseshoe kidney; subsequent T2-weighted axial magnetic resonance image (MRI) of the lumbar spine confirmed the presence of a horseshoe kidney. (C) A 39-year-old woman with bladder extrophy, pubic diastasis, and ureterosigmoidostomy. Excretion of a radiopharmaceutical via the ureterosigmoidostomy is noted in this patient with a history of bladder extrophy (arrow). (D) A 90-year-old man; whole-body bone scintigraphy, with increased uptake of a radiopharmaceutical within the left ventricle (arrows); the patient had a history of myocardial infarction. (E) A 74-year-old man with a history of breast cancer; posterior bone scintigram, demonstrating increased uptake in the ischial tuberosities bilaterally, greater on the left (arrow) than the right (arrowhead). (F) A 74-year-old man with a history of breast cancer; coronal short T1 inversion recovery (left) and T1-weighted (right) sequences from an MRI of the pelvis, demonstrating a chronic avulsion of the right hamstring tendon with avulsion of a bony fragment (arrowheads) and high signal within the left hamstring tendon, consistent with tendinopathy (arrows).
Artifacts
Medical devices, such as central venous access catheters ( Figure 13A) , can demonstrate increased uptake of a radiopharmaceutical. Patients who have had a previous radionuclide procedure, such as sentinel node injection ( Figure 13B ), can have residual radiopharmaceutical, which is detected on subsequent bone scintigraphy.
Conclusion
There are many causes of increased radiopharmaceutical uptake on bone scintigraphy. Knowledge of both the benign and malignant causes of a ''positive'' bone scan is integral to the interpretation of bone scintigraphy, which allows the recommendation of an appropriate imaging modality for further evaluation and optimum characterization of these lesions where necessary. In turn, radiologists who do not primarily report nuclear medicine examinations should be familiar with the wide range of benign bone and soft-tissue lesions that can result in increased radiopharmaceutical uptake and which may mimic metastatic disease; in some cases, this may prevent the patient from having an unnecessary invasive procedure or biopsy.
